78th Scientific Sessions Advance Program - 31

*	 Diabetes in Rural America
Disparities in the Prevention and
Management of Diabetes in Rural
America
Shivani A. Patel, PhD
Burden of Diabetes and Its
Complications among American
Indians and Alaska Natives
Spero M. Manson, PhD
How to Improve Access in Rural
America?
Matthew F. Bouchonville, MD
Policy Solutions to Improve
Diabetes Care in Rural America
Janice C. Probst, PhD
*	 Aging and Insulin Sensitivity
Metformin Action in Aging and
Cancer
Alexander Soukas, MD, PhD
Caloric Restriction and Aging-
A Focus on Metabolism
Rozalyn M. Anderson, PhD
Metabolic Defects Induced by
the Lifespan-Extending Drug
Rapamycin
Joseph A. Baur, PhD
Mitochondria and Aging
Jennifer Estall, PhD
*	 Nutrient Sensing and Signaling
in the Regulation of Metabolic
Homeostasis
Amino Acids and Metabolic Health
Mark A. Herman, MD
Mechanisms of High-Fructose DietInduced Pathology in the Liver
Dean R. Tolan, PhD
The Influence of Diet on MaternalFetal Metabolic Programming
Carrie McCurdy, PhD
Nicotinamide Adenine
Dinucleotide Metabolism and
Energy Homeostasis
Charles Brenner, PhD
Nutrient Sensing and Oxidative
Stress
Danica Chen, PhD

ORLANDO, FL | JUNE 22 - 26, 2018

*	 G-Protein-Coupled Receptors-
Structural Insights to Therapeutic
Options
Leveraging G-Protein-Coupled
Receptors and Structural Insights
Roger K. Sunahara, PhD
Designer G-Protein-Coupled
Receptors to Dissect Metabolic
Pathways
Jürgen Wess, PhD
Inhibition of Secretion by GPCR
Regulation of the Exocytotic Fusion
Machinery
Heidi E. Hamm, PhD
Targeting GLP-1 Receptor
Trafficking to Improve Agonist
Efficacy
Alejandra Tomas, PhD

10:15 a.m.-12:15 p.m.
Symposium
*	 SGLT Inhibition for Type 1
Diabetes Mellitus Management-
How Far Have We Gone?                                                                        
Understanding Metabolic Effects of
SGLT Inhibition in Type 1 Diabetes
to Explain and Avoid Increased Risk
of Diabetic Ketoacidosis
Ele Ferrannini, MD
Clinical Efficacy and Safety of
Dapagliflozin in Type 1 Diabetes-
Evidence to Date!
Paresh Dandona, MD
Empagliflozin "Ease" Development
Program to Support Regulatory
Approval
Julio Rosenstock, MD
Sotagliflozin "In Tandem"
Development Program to Support
Regulatory Approval
John B. Buse, MD, PhD
Should a Cardiovascular-Renal
Prevention Outcome Trial with an
SGLT Inhibitor Be Warranted in
Type 1 Diabetes Mellitus?
David Cherney, MD, PhD

Speakers and presentation titles are subject to change.

31



Table of Contents for the Digital Edition of 78th Scientific Sessions Advance Program

78th Scientific Sessions Advance Program - 1
78th Scientific Sessions Advance Program - 2
78th Scientific Sessions Advance Program - 3
78th Scientific Sessions Advance Program - 4
78th Scientific Sessions Advance Program - 5
78th Scientific Sessions Advance Program - 6
78th Scientific Sessions Advance Program - 7
78th Scientific Sessions Advance Program - 8
78th Scientific Sessions Advance Program - 9
78th Scientific Sessions Advance Program - 10
78th Scientific Sessions Advance Program - 11
78th Scientific Sessions Advance Program - 12
78th Scientific Sessions Advance Program - 13
78th Scientific Sessions Advance Program - 14
78th Scientific Sessions Advance Program - 15
78th Scientific Sessions Advance Program - 16
78th Scientific Sessions Advance Program - 17
78th Scientific Sessions Advance Program - 18
78th Scientific Sessions Advance Program - 19
78th Scientific Sessions Advance Program - 20
78th Scientific Sessions Advance Program - 21
78th Scientific Sessions Advance Program - 22
78th Scientific Sessions Advance Program - 23
78th Scientific Sessions Advance Program - 24
78th Scientific Sessions Advance Program - 25
78th Scientific Sessions Advance Program - 26
78th Scientific Sessions Advance Program - 27
78th Scientific Sessions Advance Program - 28
78th Scientific Sessions Advance Program - 29
78th Scientific Sessions Advance Program - 30
78th Scientific Sessions Advance Program - 31
78th Scientific Sessions Advance Program - 32
https://www.nxtbookmedia.com